Mednax, Inc. (MD): Price and Financial Metrics

MD POWR Grades

• Growth is the dimension where MD ranks best; there it ranks ahead of 89.86% of US stocks.
• The strongest trend for MD is in Growth, which has been heading down over the past 178 days.
• MD's current lowest rank is in the Sentiment metric (where it is better than 21.95% of US stocks).

MD Stock Summary

• With a year-over-year growth in debt of -17.68%, PEDIATRIX MEDICAL GROUP INC's debt growth rate surpasses only 17.68% of about US stocks.
• Over the past twelve months, MD has reported earnings growth of 228.08%, putting it ahead of 92.57% of US stocks in our set.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for MD comes in at 21.66% -- higher than that of 92.23% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to PEDIATRIX MEDICAL GROUP INC, a group of peers worth examining would be FREE, HLIO, KOP, DOOR, and PLOW.
• Visit MD's SEC page to see the company's official filings. To visit the company's web site, go to www.mednax.com.

MD Valuation Summary

• In comparison to the median Healthcare stock, MD's EV/EBIT ratio is 37.2% higher, now standing at 14.2.
• Over the past 243 months, MD's price/sales ratio has gone down 1.2.

Below are key valuation metrics over time for MD.

MD Growth Metrics

Its 4 year revenue growth rate is now at 13.38%.
• The year over year cash and equivalents growth rate now stands at -97.34%.
• The 4 year net income to common stockholders growth rate now stands at -475.08%.

Over the past 33 months, MD's revenue has gone down $1,581,122,000.

The table below shows MD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	1,959.741	90.263	84.259
2022-03-31	1,946.667	61.443	92.134
2021-12-31	1,911.191	76.737	130.964
2021-09-30	1,829.291	20.635	19.152
2021-06-30	1,796.977	129.468	-52.687
2021-03-31	1,833.221	268.863	-760.134

MD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• MD has a Quality Grade of C, ranking ahead of 56.08% of graded US stocks.
• MD's asset turnover comes in at 0.609 -- ranking 45th of 81 Healthcare stocks.
• ENZ, TDOC, and LFMD are the stocks whose asset turnover ratios are most correlated with MD.

The table below shows MD's key quality metrics over time.